Clinical Trials Directory

Trials / Conditions / Vasodilatory Shock

Vasodilatory Shock

6 registered clinical trials studyying Vasodilatory Shock2 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationSynthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension
NCT07212686
Todd SwebergPhase 4
RecruitingEfficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
NCT06351150
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3
CompletedVasopressin Use in Septic Shock From Türkiye
NCT06953297
Karadeniz Technical University
CompletedSerum Biomarkers to Predict Response to Angiotensin II in Septic Shock
NCT05824767
University of New MexicoPhase 4
TerminatedHeparin Anticoagulation in Septic Shock
NCT03378466
University of ManitobaPhase 2
Approved For MarketingExpanded Access for LJPC-501
NCT03245528
La Jolla Pharmaceutical Company